Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$65.06 1.50 (2.36%) as of 4:30 Fri 6/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 81.33(B)
Last Volume: 9,792,067 Avg Vol: 8,697,344
52 Week Range: $63.43 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,000 25,472 36,973 80,792
Total Sell Value $145,920 $2,022,270 $2,937,849 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 1 5 8 14
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 2511
  Page 5 of 101  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lofton Kevin E Director   •       •      –    2023-05-01 4 GD $0.00 $0 I/I 12,868 90,766     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-03-13 4 AS $78.99 $483,893 D/D (6,126) 70,130 1%     
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-03-10 4 D $79.50 $1,114,352 D/D (14,017) 375,766     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-03-10 4 OE $0.00 $0 D/D 30,288 389,783     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-03-10 4 D $79.50 $423,576 D/D (5,328) 76,256     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-03-10 4 OE $0.00 $0 D/D 11,454 81,584     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-03-10 4 D $79.50 $385,496 D/D (4,849) 111,188     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-03-10 4 OE $0.00 $0 D/D 10,419 116,037     -
   Patterson Sandra SVP, Controllership   •       •      –    2023-03-10 4 D $79.50 $63,680 D/D (801) 26,212     -
   Patterson Sandra SVP, Controllership   •       •      –    2023-03-10 4 OE $0.00 $0 D/D 2,921 27,013     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-03-10 4 D $79.50 $406,722 D/D (5,116) 82,225     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2023-03-10 4 OE $0.00 $0 D/D 10,976 87,341     -
   Lofton Kevin E Director   •       •      –    2023-03-09 4 OE $52.38 $442,192 D/D 8,442 8,442     -
   Patterson Sandra SVP, ControllershipOfficer   •       –      –    2023-03-01 3 IO $0.00 $0 D/D 0 24,092 -4%     
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-03-01 4 D $79.59 $385,375 D/D (4,842) 359,495     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2023-03-01 4 OE $0.00 $0 D/D 11,362 364,337     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-03-01 4 AS $79.96 $1,038,225 D/D (12,984) 70,130 -4%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-02-15 4 A $56.38 $21,199 D/D 376 105,618     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2023-02-15 4 A $56.38 $21,199 D/D 376 376     -
   Parsey Merdad Chief Medical Officer   •       •      –    2023-02-15 4 A $56.38 $21,199 D/D 376 83,114     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-02-06 4 D $86.36 $45,857 D/D (531) 105,242     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 1,817 105,773     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2023-02-06 4 D $86.36 $48,793 D/D (565) 32,010     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 1,864 32,575     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2023-01-24 4 D $84.02 $1,287,775 D/D (15,327) 103,956     -
  2511 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 101
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us